Ec HealthcareHKEX: 2138

2023/24 Annual Report

· Issued by Ec Healthcare

Contents 目錄

Key Milestones

主要里程碑

2

Financial Highlights and Five Year Summary

財務摘要及五年概要

4

EC Healthcare At A Glance

醫思健康一覽

6

Geographical Coverage

地域覆蓋

7

One-Stop,Multi-Brand Ecosystem

一站式多品牌生態系統

8

Chairman's Statement

主席報告

9

Biography of Directors and Senior Management

董事及高級管理人員簡歷

13

Management Discussion and Analysis

管理層討論及分析

20

Sustainability Approach

可持續發展方針

36

Co-Owners

持股管理人

39

Awards and Recognitions

獎項及嘉許

46

Investor Relations Report

投資者關係報告

48

Corporate Governance Report

企業管治報告

51

Report of the Directors

董事會報告

66

Independent Auditor's Report

獨立核數師報告

95

Consolidated Statement of Profit or Loss

綜合損益表

102

Consolidated Statement of Comprehensive Income

綜合全面收益表

103

Consolidated Statement of Financial Position

綜合財務狀況表

104

Consolidated Statement of Changes In Equity

綜合權益變動表

106

Consolidated Statement of Cash Flows

綜合現金流量表

107

Notes to the Financial Statements

財務報表附註

110

Corporate Information

公司資料

262

Definitions

釋義

264

This Annual Report is printed on environmentally friendly paper 本年度報告以環保紙張印刷

Key Milestones

主要里程碑

2023

2023

APR

MAY

四月

五月

Acquisition of medical aesthetics equipment

Awarded two ISO certifications

distribution business

榮獲兩項 ISO 認證

收購醫美儀器分銷業務

Signed Sustainability - Linked

Syndicated Facility

訂立可持續發展表現掛鈎銀團貸款

Strategic Collaboration with

Strategic Collaboration with

Jiangxi Rimag Group Co., Ltd.

K e r r y L o g i s t i c s N e t w o r k

與江西一脈陽光集團股份有限公

Limited

司達成戰略合作

與嘉里物流聯網有限公司達成戰

略合作

2023

NOV

十一月

2023

DEC

十二月

Acquisition of laboratory equipment distribution business

收購實驗室設備分銷業務

E C H e a l t h c a r e

2

A n n u a l R e p o r t 2 0 2 3 / 2 4

Key Milestones

主要里程碑

Multiple awards for Best Management

Team in Asia 2023 from Institutional Investor

榮獲《機構投資者》2023 亞洲區最佳管理團隊 多個獎項

2023

JUN

六月

2023

OCT

十月

Awarded HERA "Hong Kong ESG

Reporting 2023"

榮 獲 HERA「2023 年 香 港 ESG 報 告 大獎」

Hong Kong Headquarters relocated to Quarry

Bay, Hong Kong Island

香港總部遷至香港島鰂魚涌

2024

FEB

二月

醫 思 健 康

3

年 度 報 告 2 0 2 3 / 2 4

Financial Highlights and Five Year Summary

財務摘要及五年概要

Year ended 31 March 截至三月三十一日止年度

2024

2023

2022

2021

2020(8)

二零二四年

二零二三年

二零二二年

二零二一年

二零二零年(8)

HK$'000

HK$'000

HK$'000

HK$'000

HK$'000

千港元

千港元

千港元

千港元

千港元

Revenue

收入

4,211,034

3,875,377

2,919,500

2,080,403

1,948,501

EBITDA(1)

息稅折舊及攤銷前

之盈利(1)

388,132

430,270

536,364

397,354

460,414

Profit before tax

除稅前溢利

16,874

136,189

321,411

265,896

360,523

Profit for the year

年內溢利

15,695

107,027

270,503

225,593

310,272

Profit attributable to owners of

本公司擁有人應佔

  the Company

溢利

(18,947)

69,654

197,501

192,865

286,576

Basic earnings per share (HK cents)

每股基本盈利(港仙)

(1.6)

5.9

17.1

18.8

29.1

As at 31 March

於三月三十一日

2024

2023

2022

2021

2020(8)

二零二四年

二零二三年

二零二二年

二零二一年

二零二零年(8)

HK$'000

HK$'000

HK$'000

HK$'000

HK$'000

千港元

千港元

千港元

千港元

千港元

Total assets

資產總值

5,373,054

5,513,330

4,860,608

3,790,481

2,555,269

Total liabilities

負債總額

2,970,283

3,142,385

2,510,052

2,159,695

1,385,736

Net assets

資產淨值

2,402,771

2,370,945

2,350,556

1,630,786

1,169,533

Financial Metrics

財務指標

EBITDA Margin(2)

息稅折舊及攤銷前

之盈利率(2)

9.2%

11.1%

18.4%

19.1%

23.6%

Net profit margin(3)

淨溢利率(3)

0.4%

2.8%

9.3%

10.8%

15.9%

Current ratio(4)

流動比率(4)

0.92x

0.85x

1.11x

1.07x

0.98x

Quick ratio(5)

速動比率(5)

0.85x

0.80x

1.04x

1.04x

0.93x

Debt/EBITDA

債務╱息稅折舊及

攤銷前之盈利

2.4x

1.7x

0.4x

1.4x

0.7x

Gearing ratio

資產負債比率

38.3%

30.3%

10.1%

34.5%

25.9%

Return on equity(6)

股本回報率(6)

0.7%

4.5%

11.5%

13.8%

26.5%

Return on average total assets(7)

平均總資產回報率(7)

0.6%

2.1%

6.3%

7.1%

12.7%

Dividend per share (HK cents)

每股股息(港仙)

0.5

10.0

14.4

15.9

23.0

E C H e a l t h c a r e

4

A n n u a l R e p o r t 2 0 2 3 / 2 4

Financial Highlights and Five Year Summary

財務摘要及五年概要

Notes:

附註:

1.

EBITDA equals earnings before interests, taxation, depreciation-owned

1.

息稅折舊及攤銷前之盈利等於未計利息、稅項、自

property, plant and equipment and amortisation. EBITDA is not a standard

有物業、廠房及設備折舊及攤銷前的盈利。息稅折

measure under HKFRS. The Company's management believes that EBITDA,

舊及攤銷前之盈利並非香港財務報告準則下的標準

as a proxy of operating cash flow generated by the Group's businesses,

計量方法。本公司管理層認為,息稅折舊及攤銷前

provide investors with useful supplementary information to assess the

之盈利作為本集團業務所得經營現金流的代表,為

performance of the Group.

投資者提供有用的補充資料,以評估本集團的表現。

The following table sets out the reconciliation of the EBITDA and profit before

下表載列於所示期間息稅折舊及攤銷前之盈利與除

tax for the periods indicated:

稅前溢利的對賬:

Year ended

31 March

截至三月三十一日

止年度

2024

二零二四年

HK$'000

千港元

Profit before tax

除稅前溢利

16,874

Finance costs

財務成本

100,837

Depreciation-owned property, plant and equipment

折舊-自有物業、廠房及設備

177,073

Amortisation of intangible assets

無形資產攤銷

108,921

Less: Bank and other interest income (note 6 to the financial statements)

減:銀行及其他利息收入(財務報表附註6)

(15,573)

EBITDA

息稅折舊及攤銷前之盈利

388,132

2.

EBITDA Margin equals earnings before interests, taxation, depreciation-owned

2.

息稅折舊及攤銷前之盈利率等於財政年度內未計利

property, plant and equipment and amortisation over total revenue of the

息、稅項、自有物業、廠房及設備折舊及攤銷前的

financial year.

盈利除以總收入。

3.

Net profit margin equals profit for the year divided by revenue for the same

3.

淨溢利率等於年內溢利除以同期的收入。

period.

4.

Current ratio equals current assets divided by current liabilities as at the end of

4.

流動比率等於財政年度末的流動資產除以流動負債。

the financial year.

5.

Quick ratio equals current assets less inventories divided by current liabilities

5.

速動比率等於財政年度末的流動資產減存貨除以流

as at the end of the financial year.

動負債。

6.

Gearing ratio equals total debt (total debt refers to the aggregate sum of bank

6.

資產負債比率等於債務總額(債務總額指銀行借款與

borrowings and convertible bonds excluding lease liabilities relating to

可換股債券總和,與租賃作自用的物業有關的租賃

properties leased for own use) divided by total equity.

負債除外)除以權益總額。

7.

Return on equity equals profit for the year divided by the ending balance of

7.

股本回報率等於年內溢利除以財政年度的權益總額

total equity of the financial year.

之年末結餘。

8.

Return on average total assets equals profit for the year divided by the

8.

平均總資產回報率等於年內溢利除以財政年度的資

arithmetic mean of the beginning and ending balances of total assets of the

產總值之年初及年末結餘之算術平均數。

financial year.

9.

The Group has initially applied HKFRS 16, Leases on 1 April 2019 using the

9.

本集團已於二零一九年四月一日使用經修訂追溯法

modified retrospective approach. Accordingly, the figures for each of the years

首次應用香港財務報告準則第 16 號租賃。因此,截

ended 31 March 2018 and 2019 are not restated and therefore may not be

至二零一八年及二零一九年三月三十一日止各年度

comparable.

的數字並無重列,故可能無法比較。

醫 思 健 康

5

年 度 報 告 2 0 2 3 / 2 4

EC Healthcare At A Glance

醫思健康一覽

VISION

願景

To be the leading one-stop healthcare ECOSYSTEM with focus on preventive and precision medicine

成為領先的一站式大健康生態系 統,並專注於精準及預防性醫療

MISSION

使命

Bring Health, Beauty and Happiness to more People

將健康、美麗、快樂帶給更多人

CORE VALUES

核心價值

.Integrity

專業誠信

.Empathy

富同理心

.Co-Ownership

共同領導

.Disruptive Agility

靈活破格

.Excellence

非凡卓越

Medical

Aesthetic medical, beauty

and wellness services

醫療

美學醫療、美容及養生服務

Revenue (HK$ million)

2,632

Revenue (HK$ million)

1,309

收入 (百萬港元)

收入 (百萬港元)

服務點數量

126

服務點數量

46

No. of Service Points

No. of Service Points

OUR STORES

No. Service Points

182

我們的門店

服務點數量

OUR CUSTOMERS

No. of Customer Visit1

1,859,328

客戶到訪人次1

我們的客戶

Existing Customer Revenue

63.5%

Contribution3

現有客戶收入佔比3

Customer Satisfactions Rate5

99.98%

OUR PEOPLE

客戶滿意率5

No. of Registered Practitioners

337

我們的團隊

註冊醫生人數

Notes:

附註:

Veterinary and other

獸醫及其他

Revenue (HK$ million)

270

收入 (百萬港元)

No. of Service Points

10

服務點數量

Total Service Area

657,000

總服務面積

sq ft 平方呎

Repurchase Rate2

69.0%

回購率2

No. of Cross Brand

34.5%

Customers4

跨品牌客戶人數4

No. of Registered

Veterinary Surgeons

56

註冊獸醫人數

  1. Based on sales volume for the year excluding non-retail brands
    根據本年度銷售額並不包括非零售品牌
  2. Customers of FY23 contribution in FY24 divided by the total revenue in FY23
    二零二三財年客戶在二零二四財年的收入貢獻,除以二零二三財年總收入
  3. Revenue contribution by existing customers to the total revenue for the year
    現有客戶對本年度總收入的貢獻率
  4. Number of unique customers who purchased services from more than one brand for the year divided by total number of unique customers since 2018 among 34 brands
    自二零一八年以來 34 個品牌中從一個以上品牌購買服務的獨立客戶數量除以總獨立客戶數量
  5. 100% minus the percentage of material unfavourable feedback of total revenue for the year 100% 減去本年度總收入中重大不利反饋的百分比

E C H e a l t h c a r e

6

A n n u a l R e p o r t 2 0 2 3 / 2 4

Geographical Coverage

地域覆蓋

Total of 182service points across 657,000sq ft covering Greater China (as of Mar 31, 2024) 大中華區實現廣泛布局共運營 657,000平方呎 182個服務點(截至二零二四年三月三十一日)

Mainland China (exclude

Hong Kong and Macau)

中國大陸(除香港及澳門外)10

2 Shanghai 上海

Hong Kong, China 中國香港 168

1 2 1 New Territories North 新界北

New Territories North West 11 5 新界西北

10 3 1 New Territories South West 新界西南

41 7 4 Kowloon West 九龍西

Hong Kong

Island West

19 4 1 香港島西

Lantau Island 大嶼山 1

As at 31 March 2024

截至二零二四年三月三十一日

Greater Bay Area, China (exclude 14 Hong Kong) 中國大灣區(除香港外)

Guangzhou 廣州 3

Shenzhen 深圳 5

4 Macau 澳門

New Territories North East 新界東北 5 2

New Territories

South East

新界東南 8 5 1

Kowloon Central 九龍中 1

Kowloon East 九龍東 4

Hong Kong Island East 香港島東 24 7

Medical 醫療

125

Aesthetic Medical and

Beauty and Wellness

33

美學醫療以及美容及養生

Veterinarian and other

10

獸醫及其他

醫 思 健 康

7

年 度 報 告 2 0 2 3 / 2 4

One-Stop,Multi-Brand Ecosystem

一站式多品牌生態系統

46diverse brands: luxury and affordable options catering to a wide range of customers

46個多元化品牌:為各種客戶提供高端及大眾的選擇

Medical Brands

Aesthetic Medical, Beauty and

Wellness Brands

醫療品牌

32

7 美學醫療、美容及養生品牌

Preventive Care 預防醫學

Lab Testing and Screening 檢測及化驗

Primary Care and Doctor Network

基層醫療及醫生網路

Specialists 專科

7 Veterinary Brands

獸醫品牌

Pain and Wellness 痛症及養生

Dental Care 牙齒保健

E C H e a l t h c a r e

8

A n n u a l R e p o r t 2 0 2 3 / 2 4

Chairman's Statement

主席報告

Dear Shareholders,

各位尊敬的股東:

FY24 has been a challenging year for both our company and the healthcare industry. The slow recovery of the global economy and ongoing inflationary pressures continue to suppress consumer demand. Although geopolitical tensions have eased somewhat, instability in certain regions still affects market sentiment. Additionally, the current high-interest-rate environment, inflationary pressures, and economic uncertainties present unprecedented challenges to our business.

二零二四財年對公司及整個醫療保健行業而言,同樣是充滿挑戰 的一年。全球經濟復蘇緩慢和持續的通脹壓力繼續抑制消費需 求。儘管地緣政治緊張局勢有所緩解,但某些地區的不穩定性仍 然影響市場情緒。此外,現行的高息環境、通脹壓力及經濟不確 定性為我們的業務帶來了前所未有的挑戰。

The market environment in Hong Kong is particularly complex and

香港目前的市場環境複雜多變,面臨諸多挑戰。

volatile, presenting multiple challenges. Firstly, the number of

首先,國際及內地遊客的訪港人數尚未恢復至疫

international and Mainland visitors to Hong Kong has not yet returned

情前水平,消費降級嚴重影響了旅遊業和相關行

to pre-pandemic levels, and downgraded consumption severely

業的復蘇。同時,香港本地股票市場和房地產市

impacts the recovery process of tourism and related industries.

場的波動產生了負面的財富效應,導致本地消費

Meanwhile, fluctuations in the local stock and real estate markets have

情緒整體下降。香港居民頻繁赴內地和國際旅

created negative wealth effects, leading to a general decline in local

遊,這進一步分散了本地市場的消費能力,影響

consumer sentiment. Frequent travel of Hong Kong residents to

了零售和服務業的收入增長。此外,香港勞動人

Mainland China and internationally further disperses local market

口的下降加劇了招聘難度,延長了招聘周期並推

spending power, affecting revenue growth in the retail and service

高了成本,給企業的人力資源管理帶來巨大壓力。

sectors. Additionally, the declining labour force in Hong Kong has

exacerbated recruitment difficulties, extended hiring cycles, and

increased costs, posing significant pressures on human resources

management.

醫 思 健 康

9

年 度 報 告 2 0 2 3 / 2 4

Earlier from Ec Healthcare

All Ec Healthcare news releases